Free Trial

Owens & Minor, Inc. (NYSE:OMI) Given Consensus Recommendation of "Hold" by Brokerages

Owens & Minor logo with Medical background

Shares of Owens & Minor, Inc. (NYSE:OMI - Get Free Report) have received a consensus rating of "Hold" from the eight brokerages that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $18.50.

Several research firms have recently weighed in on OMI. Barclays reduced their target price on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 5th. UBS Group lowered their target price on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Citigroup dropped their target price on Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird reduced their price target on Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a research report on Tuesday, November 5th. Finally, StockNews.com cut Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th.

View Our Latest Report on OMI

Insider Activity at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm's stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares of the company's stock, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.62% of the stock is owned by corporate insiders.

Institutional Trading of Owens & Minor

Several institutional investors and hedge funds have recently made changes to their positions in OMI. Quarry LP boosted its stake in Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company's stock worth $28,000 after buying an additional 1,561 shares in the last quarter. Innealta Capital LLC bought a new position in shares of Owens & Minor during the 2nd quarter valued at $43,000. DekaBank Deutsche Girozentrale raised its position in Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after purchasing an additional 1,356 shares during the period. Blue Trust Inc. lifted its stake in Owens & Minor by 176.8% in the third quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock worth $44,000 after purchasing an additional 1,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in Owens & Minor by 100.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company's stock valued at $82,000 after buying an additional 3,044 shares during the period. Hedge funds and other institutional investors own 98.04% of the company's stock.

Owens & Minor Stock Performance

Shares of NYSE:OMI traded down $0.46 during mid-day trading on Tuesday, reaching $13.19. The company had a trading volume of 471,798 shares, compared to its average volume of 824,208. Owens & Minor has a one year low of $11.42 and a one year high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The company's 50-day moving average price is $13.71 and its 200-day moving average price is $15.13. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of -20.29, a PEG ratio of 0.43 and a beta of 0.41.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. During the same period in the previous year, the company posted $0.44 earnings per share. The business's revenue was up 5.0% on a year-over-year basis. As a group, equities research analysts anticipate that Owens & Minor will post 1.49 EPS for the current fiscal year.

About Owens & Minor

(Get Free Report

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines